Irrigular periods
Reading File
Searching sources...
Finding Sources
Finding Sources
Searching PubMed
"irregular menstruation" OR "oligomenorrhea" causes management
Reading File
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Here is a thorough overview of irregular periods (oligomenorrhea/abnormal uterine bleeding) drawn from authoritative gynecology textbooks.
Irregular Periods
What Is "Irregular"?
A normal menstrual cycle lasts 21 to 35 days, with bleeding lasting 2-7 days. A period is considered irregular when:
- Cycle length is > 35 days (oligomenorrhea - infrequent periods)
- Cycles are < 9 per year
- Cycle length varies widely from month to month
- Secondary amenorrhea: no period for 3 cycles or 3 months in someone who previously menstruated
(Berek & Novak's Gynecology)
How Normal Menstruation Works
A healthy period requires a precise hormonal chain reaction:
- Hypothalamus releases GnRH in a pulsatile pattern
- GnRH stimulates the pituitary to release FSH and LH
- FSH/LH drive ovarian follicle development and ovulation
- The ovary produces estrogen (pre-ovulation) and progesterone (post-ovulation)
- These hormones prime the endometrium; when they drop, withdrawal bleeding occurs
If any link in this chain is disrupted - hypothalamus, pituitary, ovary, uterus, or outflow tract - periods become irregular or absent.
Common Causes
The PALM-COEIN classification (ACOG) organizes causes into structural and non-structural:
| PALM - Structural | COEIN - Non-Structural |
|---|---|
| Polyps | Coagulopathy |
| Adenomyosis | Ovulatory dysfunction |
| Leiomyoma (fibroids) | Endometrial causes |
| Malignancy / Hyperplasia | Iatrogenic (medications) |
| Not yet classified |
(Textbook of Family Medicine, 9e)
Most Common Causes by Category
Anovulatory (most common overall):
- PCOS (Polycystic Ovary Syndrome) - leading cause in reproductive-age women
- Hypothalamic dysfunction: weight loss, eating disorders, excessive exercise, female athlete triad, chronic illness, stress
- Thyroid disorders (hypo- or hyperthyroidism)
- Hyperprolactinemia (elevated prolactin from pituitary adenoma or medications)
- Medication-induced (e.g., stopping hormonal contraceptives)
Structural:
- Uterine fibroids
- Endometrial polyps
- Cervical pathology
- Intrauterine device (IUD)
In adolescents: It is normal for cycles to be irregular for up to 18 months after menarche, while the hypothalamic-pituitary axis matures.
In perimenopause: Fluctuating hormone levels naturally cause irregular cycles.
The Key Pathology: Anovulation
The most important underlying mechanism in most cases is anovulation - failure to ovulate. Without ovulation:
- No progesterone is produced
- Estrogen acts unopposed on the endometrium
- Different parts of the endometrium shed at different times, causing unpredictable, erratic bleeding
A woman with anovulation may experience: heavy bleeding for 14 days one month, light spotting the next, then no period for 3 months. This unpredictability is the hallmark.
When to Worry
Irregular periods can be a sign of a serious underlying condition. Evaluation is warranted if:
- Fewer than 9 cycles per year
- Cycle > 35 days or < 21 days
- Prolonged unopposed estrogen exposure (risk of endometrial hyperplasia/cancer)
- Associated symptoms: weight gain, hair growth/loss, acne (suggests PCOS or thyroid disease)
- Trying to conceive
Diagnostic Workup
| Test | What It Checks |
|---|---|
| Pregnancy test (hCG) | Always first - rule out pregnancy |
| TSH | Thyroid function |
| Prolactin | Hyperprolactinemia |
| FSH + Estradiol | Ovarian reserve; distinguish hypo vs. hypergonadotropic states |
| CBC | Anemia if heavy/frequent bleeding |
| Fasting glucose + insulin | Screen for PCOS/insulin resistance |
| Pelvic ultrasound | Fibroids, polyps, ovarian cysts |
| AMH | Ovarian reserve (optional) |
| Endometrial biopsy | Recommended in women > 35 years to exclude hyperplasia |
(Berek & Novak's Gynecology; Textbook of Family Medicine, 9e)
Treatment
Treatment depends on the cause and the patient's goals:
| Goal | Options |
|---|---|
| Cycle regulation | Combined oral contraceptive pill (OCP), progesterone-only pill, hormonal IUD |
| Prevent endometrial hyperplasia | Cyclic/continuous progesterone is mandatory in anovulatory women |
| Pregnancy desired | Clomiphene citrate (ovulation induction); referral to gynecologist |
| PCOS | Weight loss, OCP, metformin |
| Thyroid/prolactin disorders | Treat the underlying condition directly |
| Heavy acute bleeding | High-dose estrogen or progesterone; tranexamic acid |
Important: All women with chronic anovulation (unopposed estrogen) need progesterone protection to reduce the risk of endometrial cancer, regardless of whether the bleeding bothers them.
Recent Evidence
A 2026 systematic review and meta-analysis (PMID 41177002) found that menstrual irregularities are independently associated with increased cardiometabolic risk (cardiovascular disease, diabetes), reinforcing that irregular periods are not just a reproductive issue but a broader health marker. A 2024 systematic review (PMID 38950686) confirmed that psychological stress is a significant driver of menstrual irregularity.
Bottom line: Irregular periods are most often caused by anovulation, with PCOS, thyroid disorders, hyperprolactinemia, and lifestyle factors (stress, weight changes, exercise) being the top culprits. A pregnancy test is always the first step. The main concern with untreated anovulation is unopposed estrogen leading to endometrial hyperplasia - so progesterone is a key part of management even when bleeding seems tolerable.
Medicine for vomiting
Finding Sources
Finding Sources
Searching PubMed
antiemetic drugs nausea vomiting
Reading File
Reading File
Medicines for Vomiting (Antiemetics)
Antiemetic choice depends on the underlying cause of nausea/vomiting - different receptor pathways drive different types of vomiting (chemotherapy-induced, motion sickness, postoperative, gastroenteritis, pregnancy, vestibular disease). Below is an overview by drug class, drawn from Goodman & Gilman's Pharmacology, Roberts and Hedges' Clinical Procedures in Emergency Medicine, and related texts.
1. Serotonin (5-HT3) Receptor Antagonists
- Ondansetron, granisetron, palonosetron
- First-line for chemotherapy-induced and postoperative nausea and vomiting (PONV)
- Block 5-HT3 receptors in the gut vagal afferents and the chemoreceptor trigger zone (CTZ)
- Ondansetron ODT (orally dissolving tablet) has largely replaced rectal antiemetics in emergency settings because it's better tolerated
- Generally well tolerated; can prolong QT interval at higher doses
2. Dopamine (D2) Receptor Antagonists
- Prochlorperazine, promethazine, metoclopramide
- Block D2 receptors in the CTZ; metoclopramide also promotes gastric emptying (prokinetic)
- Prochlorperazine and promethazine are the two most common antiemetics given rectally in the ED (as suppositories) when IV access is delayed or oral routes have failed - useful for gastroenteritis or when a patient can't tolerate oral intake
- Side effects: sedation, extrapyramidal symptoms (dystonia, akathisia), especially with prochlorperazine/metoclopramide
3. Antihistamines (H1 antagonists) / Anticholinergics
- Diphenhydramine, meclizine, cyclizine, dimenhydrinate, scopolamine (transdermal)
- Main indication: motion sickness and vestibular disease (vertigo-related vomiting)
- Cyclizine also useful for postoperative vomiting
- Best given before the anticipated motion trigger - treatment after nausea has already started is rarely effective
- Sedation is the main side effect
4. Benzodiazepines
- Lorazepam
- Not a primary antiemetic, but useful adjunct for anticipatory nausea (e.g., before chemotherapy) and breakthrough chemotherapy-induced nausea/vomiting (CINV)
- Higher doses improve antiemetic effect but adverse effects (sedation) become dose-limiting
5. Corticosteroids
- Dexamethasone
- Used prophylactically for PONV and as part of CINV prevention regimens (often combined with a 5-HT3 antagonist ± NK1 antagonist)
6. NK1 Receptor Antagonists
- Aprepitant, fosaprepitant
- Used mainly for highly emetogenic chemotherapy, often in combination regimens with a 5-HT3 antagonist and dexamethasone
7. Atypical Antipsychotics
- Olanzapine
- Increasingly used for refractory CINV and as prophylaxis for PONV (D2/5-HT2 antagonism)
Choosing by Cause
| Cause | Preferred agent(s) |
|---|---|
| Chemotherapy-induced | Ondansetron/granisetron + dexamethasone ± aprepitant; olanzapine for refractory cases |
| Postoperative (PONV) | Ondansetron, dexamethasone, olanzapine |
| Motion sickness/vestibular | Meclizine, scopolamine, dimenhydrinate, cyclizine (given before travel) |
| Gastroenteritis/general ED nausea | Ondansetron ODT; promethazine or prochlorperazine (IV or rectal) |
| Diabetic ketoacidosis-related | IV fluids first; antiemetics as adjuncts |
| Anticipatory/breakthrough (chemo) | Lorazepam |
Recent Evidence
- A 2024 Bayesian network meta-analysis (PMID 39465444) evaluated antiemetics for preventing chemotherapy-induced nausea and vomiting in children, supporting combination regimens including dexamethasone.
- A 2024 systematic review (PMID 38513297) found olanzapine effective as prophylaxis against PONV after general anesthesia.
- A 2025 meta-analysis (PMID 40550034) found that combining penehyclidine with standard antiemetics improved PONV prevention over standard therapy alone (note: penehyclidine is primarily used in Chinese clinical practice, not widely available elsewhere).
Important: If vomiting is persistent, associated with severe abdominal pain, blood, dehydration, neurological symptoms, or occurs in pregnancy/infancy, this needs clinical evaluation rather than self-treatment with over-the-counter antiemetics - the underlying cause (obstruction, infection, increased intracranial pressure, DKA, etc.) needs to be identified and treated. If you're dealing with a specific situation (which drug, which population, or which cause), let me know and I can narrow this down further.
This is a shared conversation. Sign in to Orris to start your own chat.